Nicholas Osborne

22PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMolecular targetsGene mappingHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Mar 28, 2026
Effects of Proglumide with Chemotherapy on the Pancreatic Tumor Microenvironment: Phase 1 PROGEM Trial.

Jill P Smith, Gakiza C Nkulikiyimana, Hong Cao

|Dec 11, 2025
Downregulation of the CCK-B Receptor in Pancreatic Stellate Cells Blocks Molecular Proliferative Pathways and Increases Apoptosis to Decrease Pancreatic Cancer Growth In Vitro.

Miranda Ortega, Eri Agena, Wenqiang Chen

|Sep 27, 2025
Mechanistic Insights into Proglumide's Role in Immune Cell Efficacy and Response to Immune Checkpoint Inhibitor Therapy in Hepatocellular Carcinoma.

Priyanka S Doneparthi, Hong Cao, Wenqiang Chen

|Apr 30, 2025
Allelic effects on KLHL17 expression underlie a pancreatic cancer genome-wide association signal at chr1p36.33.

Katelyn E Connelly, Katherine Hullin, Ehssan Abdolalizadeh

|Apr 03, 2025
Target-Specific Locked Nucleic Acid Gapmer Decreases Growth and Metastases of Pancreatic Cancer.

Jill P Smith, Narayan Shivapurkar, Wenqiang Chen

|May 25, 2024
The Role of a Cholecystokinin Receptor Antagonist in the Management of Chronic Pancreatitis: A Phase 1 Trial.

Victor Ciofoaia, Wenqiang Chen, Bakain W Tarek

Pageof 4

Frequent Collaborators

3 joint publications

Wenqiang Chen

3 joint publications

Stephan T Stern

2 joint publications

Narayan Shivapurkar

2 joint publications

Yaoxiang Li